Drug Discovery Centers

PharmaCenter Bonn

Therapeutic Approaches: Biologics, Small Molecules, Biomarkers, Stem Cells, Gene Therapy, Drug Delivery, Drug Devices

Therapeutic Areas of Expertise: Cardiology, Gene-Therapy, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Psychiatric Disorders, Pain, Regenerative Medicine, CNS Disorders

Center/Program Highlights:About us
The major aim of the PharmaCenter Bonn (PZB) is to investigate pharmaceutical principles and to develop novel therapeutic approaches. The latter encompasses the development of new drugs, the study of mechanism of action and research on and development of experimental therapies, for example, based on stem cells and RNA interference.

As an interface of basic research to application (in the form of new drugs and therapies), the PZB plays an important role in the integration of all major participants in this process. In particular, the PZB provides a link between basic biomedical research at the University of Bonn and other research institutions (ceasar, Max-Planck-Gesellschaft, Helmholtz research centers) to pharmaceutical and biotechnology companies (especially Life & Brain GmbH) and to the Federal Institute for Drugs and Medical Devices (BfArM).

Finally, it is an important goal to initiate cooperation between the PharmaCenter and the neighbouring universities (ABCD-Universities: Aachen-Bonn-Cologne-Duesseldorf), the Max-Planck Institute for the Biology of Ageing in Cologne and the Fraunhofer-Institute in St. Augustin.

Sources of Funding: Federal/State, Industry Partnerships, University